News Briefing channel feed – Endpoints News

News Briefing channel feed

Seagen's Tukysa label expanded; ADARx gets $46M script for RNA trial

3 years ago

Caris gets $400M loan from OrbiMed and Braidwell; bluebird stock sales brings in $120M

3 years ago

Aeterna discontinues vaccine development; Idera rebrands as Aceragen

3 years ago

FDA puts Vertex’s new Type 1 diabetes cell therapy IND on hold; Insilico sets up for PhII of AI drug

3 years ago

FDA accepts one, delays another; Data, deals and dollars for slate of biotechs

3 years ago

Three biotechs start the year with job cuts; Regeneron expands deal with bluebird spinout

3 years ago

Y-mAbs cuts 35% of staff; Genentech re-ups Nimble deal; Landos shifts focus; and more

3 years ago

Jasper Therapeutics sees a stock boost after sickle cell data release; Newron lifts the veil on data for schizophrenia treatment

3 years ago

News wrap: Equillium axes Metacrine merger; Two pharmas pen ADC deals

3 years ago

SPAC extends deadline to merge — again; Flagship's Evelo borrows $45M to refinance debt

3 years ago

Novavax plans to raise $250M through stock, debt sales; Penny stock company plans reverse merger

3 years ago

Boehringer Ingelheim buys CD38 drug; Merck bets on machine learning in antibody design

3 years ago

Prothena nets more cash from Novo Nordisk; Khondrion fails to hit endpoint

3 years ago

PaxMedica surges after financing; Marinus makes China development and sales pact

3 years ago

Kriya acquires gene therapy startup for undisclosed sum; Compugen wins milestone payment from AstraZeneca

3 years ago

ElevateBio and Affini-T partner on KRAS therapies; Casma raises $46M to drug the cell’s garbage disposal system

3 years ago

Sensorion nabs rare pediatric designation for gene therapy; Avalo sells off remaining drug rights for $5M

3 years ago

Santhera lays out options in bid for commercialization funds; Swiss biotech’s Covid work narrows

3 years ago

Basilea’s cancer pipeline slimdown continues; Aquestive looks to outlicense seizure drug in US

3 years ago

2seventy inks T cell partnership with Chinese biotech; Antisense drug causes brain side effect — report

3 years ago

Everest climbs closer to Covid-19 booster market; A French upstart snags funds to find drugs

3 years ago

Pfizer nabs equity stake in Swiss biotech working on celiac therapy; Verona gets more cash after COPD win

3 years ago

BioMarin heads to FDA with hemophilia A gene therapy; Covid-focused biotech signs a small SPAC deal

3 years ago

Moderna gets Autolus targeting tech via licensing deal; Atai reports PhI data for kratom-based therapy

3 years ago

First page Previous page 19 20 212223 24 25 Next page Last page